Predictive Value of Plasma Thrombomodulin in Preeclampsia and Gestational Hypertension

Marie-Claire Boffa; Luca Valsecchi; Alfonso Fausto; Danielle Gozin; Silvana Vigano’ D’Angelo; Omid Safa; Maria Teresa Castiglioni; Jean Amiral; Armando D’Angelo

doi:10.1055/s-0037-1615021

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1998; 79(06): 1092-1095
DOI: 10.1055/s-0037-1615021

Rapid Communication

Schattauer GmbH

Predictive Value of Plasma Thrombomodulin in Preeclampsia and Gestational Hypertension

Autor*innen

Marie-Claire Boffa

¹From the INSERM Unité 353, Hôpital Saint-Louis, Paris, France
Luca Valsecchi

²From the Cattedra di Ostetricia e Ginecologia, Milano, Italy
Alfonso Fausto

²From the Cattedra di Ostetricia e Ginecologia, Milano, Italy
Danielle Gozin

¹From the INSERM Unité 353, Hôpital Saint-Louis, Paris, France
Silvana Vigano’ D’Angelo

³From the Servizio di Coagulazione, Istituto Scientifico H S. Raffaele, Milano, Italy
Omid Safa

³From the Servizio di Coagulazione, Istituto Scientifico H S. Raffaele, Milano, Italy
Maria Teresa Castiglioni

²From the Cattedra di Ostetricia e Ginecologia, Milano, Italy
Jean Amiral

⁴From the Serbio, Gennevilliers, France
Armando D’Angelo

³From the Servizio di Coagulazione, Istituto Scientifico H S. Raffaele, Milano, Italy

Abstract

Summary

In a prospective longitudinal study, 130 primigravidae at risk for preeclampsia were examined and plasma sampling performed in 45 of them. Plasma thrombomodulin (pTM) was sequentially measured at weeks 12, 24 and 32 of gestation and after delivery in 20 primigravidae who developed either mild preeclampsia (n = 8) or gestational hyper-tension (n = 12) between weeks 32 and 39 of gestation and in 25 (age-matched) primigravidae who had uneventful pregnancies. pTM elevations were not observed until week 32 in uneventful pregnancies, but were present by week 24 (p = 0.002) in patients who later developed hypertensive complications. A net individual pTM increase ≥4.2 ng/ml between weeks 12 and 24 (more than 8 times that of normotensive primigravidae) and/or pTM level ≥47.5 ng/ml at week 32 predicted the development of hypertensive complications with 80% accuracy. Serial pTM determinations can be useful to select pregnancies who may benefit from early pharmacological intervention.

Volltext

Referenzen

References
1 Aznar J, Gilalbert J, Estellés A, España F. Fibrinolytic activity and protein C in preeclampsia.. Thromb Haemost 1986; 55: 314-7.
2 Perry KG, Martin Jr. JN. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia.. Clin Obstet Gynecol 1992; 35: 338-50.
3 Hustin J, Foldart JM, Lambotte R. Maternal vascular lesions in preeclampsia and intrauterine growth retardation: light microscopy and immunofluorescence.. Obstet Gynecol Survey 1985; 40: 145-9.
4 Esmon CT, Schwarz HP. An update on clinical and basic aspects of the protein C anticoagulant pathway.. Trends Cardiovasc Med 1995; 5: 141-8.
5 Maruyama I, Bell CE, Majerus PW. Thrombomodulin is found on endothelium of arteries, veins, capillaries and lymphatics, and on syncytiotropho-blast of human placenta.. J Cell Biol 1985; 101: 363-71.
6 Pruna A, Peyri N, Berard M, Boffa M-C. Thrombomodulin is synthesized by human mesangial cells.. Kidney Int 1997; 51: 687-93.
7 Boffa M-C. Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker.. Haemostasis 1996; 26 (04) 233-43.
8 Minakami H, Takahashi T, Izumi A, Tamada T. Increased levels of plasma thrombomodulin in preeclampsia.. Gynecol Obstet Invest 1993; 36: 208-10.
9 Hsu CD, Iriye B, Johnson TR, Witter FR, Hong SF, Chan DW. Elevated circulating thrombomodulin in severe preeclampsia.. Am J Obstet Gynecol 1993; 169: 148-9.
10 Bontis J, Vavilis D, Agorastos T, Zournatzi V, Konstantinidis T, Tagou K. Maternal plasma level of thrombomodulin is increased in mild preeclampsia.. Eur J Obstet Gynecol 1995; 60: 139-41.
11 Labarrere CA, Faulk WP. Microvascular perturbations in human allografts: analogies in preeclamptic placentae.. Am J Reproduc Immunol 1992; 27: 109-16.
12 Davey DA, McGillvray J. The classification and definition of the hypertensive disorders of pregnancy.. Am J Obstet Gynecol 1988; 158: 592.
13 ACOG.. Management of preeclampsia.. Washington DC: American College of Obstetricians and Gynecologists; 1986. (Technical Bulletin n 91).
14 Amiral J, Adam M, Mimilla F, Larrivaz I, Chambrette B, Boffa M-C. Design and validation of a new immunoassay for soluble forms of thrombomodulin and studies on plasma.. Hybridoma 1994; 13: 205-13.
15 Metz CE. Basic principles of ROC analysis.. Semin Nucl Med 1978; 8: 283-98.
16 Goldman L. Quantitative aspects of clinical reasoning.. In: “Harrison’s Principles of Internal Medicine”.. Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK. eds. New York: McGraw-Hill; 1991: 5-11.
17 Boffa M-C, Aurousseau MH, Wiesel ML, Grunebaum L, Cazenave JP. Variations of thrombomodulin levels due to age and sex.. Blood 1991; S1 (78) 221 (Abst).
18 Hsu CD, Lucas RB, Johnson TR, Hong SF, Chan DW. Elevated urine thrombomodulin/creatinine ratio in severely preeclamptic pregnancies.. Am J Obstet Gynecol 1994; 171: 854-6.
19 Hsu CD, Copel JA, Hong SF, Chan DW. Thrombomodulin levels in preeclampsia, gestational hypertension and chronic hypertension.. Obstet Gynecol 1995; 86: 897-9.
20 Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of preeclampsia by early anti-platelet therapy.. Lancet 1985; 1: 840-4.
21 Wallemburg HCS, Dekker GA, Makowitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae.. Lancet 1986; 1: 1-6.
22 Italian Study of aspirin in pregnancy.. Low dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hyper-tension.. Lancet 1993; 341: 396-400.
23 CLASP: a randomized trial of low-dose aspirin fro the prevention and treatment of preeclampsia among 9364 pregnant women.. Lancet 1994; 343: 619-29.
24 Collins E, Turner G. Maternal effects of regular salicylate ingestion in pregnancy.. Lancet 1975; 2: 335-8.
25 Sibai BM, Caritis SN, Thom E, Klebanoff M, McNallis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M, Depp R. The National Institute of Child Health, and the Human Development Network of Maternal-Fetal Medicine Units.. Prevention of preeclampsia with low-dose aspirin in healthy nulliparous pregnant women.. New Engl J Med 1993; 329: 1213-8.
26 Halligan A, Bonnar J, Sheppard B, Darling M, Walsh J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and preeclampsia.. Br J Obstet Gynecol 1994; 101: 488-92.
27 Alessi MC, Boffa M-C, Menart C, Aillaud MF, Parrot G, Juhan Vague I. Venous occlusion does not induce the release of thrombomodulin from endothelial cells in patients with thromboembolic disease.. Thromb Haemost 1992; 68: 483-4.
28 Abe H, Okajima K, Okabe H, Takatsuki K, Binder BR. Granulocyte pro-teases and hydrogen peroxide synergistically inactivate thrombomodulin of endothelial cells in vitro.. J Lab Clin Med 1994; 123: 874-81.
29 Boehme MWJ, Deng Y, Raeth U, Bierhaus A, Ziegler R, Stremmel W, Nawroth PP. Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies.. Immunology 1996; 87: 134-40.
30 Greer IA, Dawes J, Johnston TA, Calder AA. Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension.. Obstet Gynecol 1991; 78: 28-32.
31 Tsukimori K, Maeda H, Ishida K, Nagata H, Koyanagi T, Nakano H. The superoxide generation of neutrophils in normal and preeclamptic pregnancies.. Obstet Gynecol 1993; 81: 536-40.
32 Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Matsuda T. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure.. Am J Hematol 1991; 38: 281-7.